Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIRVANA: Cardiovis Colesterolo in Hypercholesterolemia
NCT03216811Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Ferrara
- Start
- Jul 2017
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Azienda Ospedaliero-Universitaria di Ferrara. Primary endpoint: Low-Density Lipoprotein Cholesterol at 8 weeks. Started Jul 2017; status: completed.
Beyond the preview
Go deeper on NCT03216811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216811.